CSIMarket

Prolung Inc.  (FRES)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 4
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -5
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Prolung Inc.


   Company Address: 350 W. 800 N. Salt Lake City 84103 UT
   Company Phone Number: 736â??0729   Stock Exchange / Ticker: FRES
   FRES is expected to report next financial results on August 15, 2022.


   

Stock Performances by Major Competitors

Year to Date Decrease / Increase
     
• View Complete Report
   



Medtronic Plc

Medtronic Plc announced a -1.21 %, decrease in their top-line in the fourth quarter of 2022

Although revenue fell in the fourth quarter of 2022, company managed to grow its earnings per share, eps grew by 10.35 % to $1.11 per share while Sales fell by -1.21% to $8.09 billions, year on year.

Magellan Gold Corporation

Redemption of Losses by Magellan Gold Corporation in the financial first quarter of 2022 statement

In the financial first quarter of 2022 Magellan Gold Corporation decreased loss of $-0.01 per share compared to $-0.11 a year ago and improved from $-0.02 per share from the previous quarter.

Calamp Corp.

Loss on Weak Sales at Calamp Corp in the fiscal period ending May 31 2022

In the fiscal period ending May 31 2022 Calamp Corp increased losses of $-0.34 per share compared to $-0.17 a year ago and increased losses from $-0.26 per share from the previous quarter.

Gms inc.

Impressive Quarter

Company's fourth quarter of 2022 earnings per share more than doubled by 127.27 % to $1.75 per share compared to a year ago on growing Sales of 38.24% to $1.29 billions.

Vistagen Therapeutics Inc.

Critical quarter for Vistagen Therapeutics Inc in the fiscal fourth quarter of 2022

In the fiscal fourth quarter of 2022 Vistagen Therapeutics Inc lost money of $-0.08 per share compared to $-0.20 a year ago and increased losses from $-0.05 per share from the previous quarter.






 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ESSC's Profile

Stock Price

ESSC's Financials

Business Description

Fundamentals

Charts & Quotes

ESSC's News

Suppliers

ESSC's Competitors

Customers & Markets

Economic Indicators

ESSC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071